NCT03590223View on ClinicalTrials.gov

Glycosylated Hemoglobin and Risk of Perioperative Major Cardiovascular Events in Diabetic Patients Undergoing Coronary Bypass Revascularization (HbA1c)

CompletedOBSERVATIONAL

Enrollment

589

Participants

Timeline

Start Date

December 29, 2017

Primary Completion Date

August 21, 2018

Study Completion Date

August 21, 2018

Conditions

Cardiovascular EventCoronary Artery Bypass GraftDiabetes Mellitus

Interventions

PROCEDURE

Coronary Bypass Revascularization

analysis of perioperative major cardiovascular events in diabetic patients

Trial Locations (1)

4031

Herzchirurgie University Hospital Basel, Basel

All Listed Sponsors

lead

University Hospital, Basel, Switzerland

OTHER

NCT03590223 - Glycosylated Hemoglobin and Risk of Perioperative Major Cardiovascular Events in Diabetic Patients Undergoing Coronary Bypass Revascularization (HbA1c) | Biotech Hunter | Biotech Hunter